Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Jagsonpal Pharmaceuticals had annual revenue of 2.87B INR with 6.89% growth. Jagsonpal Pharmaceuticals had revenue of 642.03M in the quarter ending March 31, 2026, with 9.64% growth.

• Revenue: 2.87B
• Revenue Growth: +6.89%
• P/S Ratio: 4.71
• Revenue / Employee: 2.05M
• Employees: 1,399
• Market Cap: 13.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.87B	185.09M	6.89%
Mar 31, 2025	2.69B	600.14M	28.76%
Mar 31, 2024	2.09B	-280.12M	-11.83%
Mar 31, 2023	2.37B	191.30M	8.79%
Mar 31, 2022	2.18B	296.38M	15.77%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error